144 related articles for article (PubMed ID: 34754678)
1. Breast Apocrine Carcinoma Detected Incidentally as Axillary Lymphadenopathy in a CT Scan.
Barron M; Asaad A; Idaewor P; Rasheed N; Saad Abdalla Al-Zawi A
Cureus; 2021 Oct; 13(10):e18523. PubMed ID: 34754678
[TBL] [Abstract][Full Text] [Related]
2. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
3. Low-grade Apocrine Intraductal Carcinoma: Expanding the Morphologic and Molecular Spectrum of an Enigmatic Salivary Gland Tumor.
Bishop JA; Gagan J; Krane JF; Jo VY
Head Neck Pathol; 2020 Dec; 14(4):869-875. PubMed ID: 31989433
[TBL] [Abstract][Full Text] [Related]
4. A rare case of apocrine carcinoma of the breast: Cytopathological and immunohistopathological study.
Khandeparkar SG; Deshmukh SD; Bhayekar PD
J Cytol; 2014 Apr; 31(2):96-8. PubMed ID: 25210239
[TBL] [Abstract][Full Text] [Related]
5. Histiocytoid breast carcinoma, neither lobular nor ductal? A case report and literature review.
Ma XL; Du Q; Liu Y; Zhao RM; Zhang SY; Zhao HF
Transl Cancer Res; 2020 Nov; 9(11):7372-7378. PubMed ID: 35117337
[TBL] [Abstract][Full Text] [Related]
6. Apocrine carcinoma of the breast.
Yamazaki M; Nagata Y; Monji S; Shigematsu Y; Baba T; Shimokawa H; Uramoto H; Yamada S; Hanagiri T; Tanaka F
J UOEH; 2011 Dec; 33(4):293-301. PubMed ID: 22259834
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative apocrine carcinoma as a rare cause of a breast lump in a Syrian female: a case report and review of the literature.
Ismail S; Kherbek H; Skef J; Zahlouk N; Abdulal R; Alshehabi Z
BMC Womens Health; 2021 Nov; 21(1):396. PubMed ID: 34823507
[TBL] [Abstract][Full Text] [Related]
8. Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor-Positive Subset of Triple-Negative Breast Cancers.
Mills AM; E Gottlieb C; M Wendroth S; M Brenin C; Atkins KA
Am J Surg Pathol; 2016 Aug; 40(8):1109-16. PubMed ID: 27259012
[TBL] [Abstract][Full Text] [Related]
9. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
D'Arcy C; Quinn C
J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
[TBL] [Abstract][Full Text] [Related]
10. Apocrine adenocarcinoma of the breast: A rare special subtype with divergent theranostic markers.
Sujata S; Sudeep K; Taruna Y; Mahendra L
J Cancer Res Ther; 2023; 19(2):477-479. PubMed ID: 37313919
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy.
Montagna E; Cancello G; Pagan E; Bagnardi V; Munzone E; Dellapasqua S; Viale G; Mazzarol G; Veronesi P; Galimberti V; Santomauro G; Colleoni M
Breast; 2020 Oct; 53():138-142. PubMed ID: 32795829
[TBL] [Abstract][Full Text] [Related]
12. Mixed Invasive Apocrine Papillary/Micropapillary Carcinoma of the Breast: Another Brick in the Triple-Negative Wall.
Cima L; Mirabassi N; Sartori C; Carbone FG; Morelli L; Cserni G; Barbareschi M
Int J Surg Pathol; 2021 Jun; 29(4):420-426. PubMed ID: 32909476
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report.
Yang P; Peng SJ; Dong YM; Yang L; Yang ZY; Hu XE; Bao GQ
World J Clin Cases; 2020 Dec; 8(23):6036-6042. PubMed ID: 33344602
[TBL] [Abstract][Full Text] [Related]
14. Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes.
Micello D; Bossi A; Marando A; Dainese E; Sessa F; Capella C
Virchows Arch; 2017 Jul; 471(1):13-21. PubMed ID: 28550498
[TBL] [Abstract][Full Text] [Related]
15. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
Goldstein NS; O'Malley BA
Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
[TBL] [Abstract][Full Text] [Related]
16. Incidental detection of breast apocrine carcinoma via endometrial cytology.
Shiota M; Kotani Y; Umemoto M; Tobiume T; Hoshiai H
Tohoku J Exp Med; 2011 Dec; 225(4):235-7. PubMed ID: 22041622
[TBL] [Abstract][Full Text] [Related]
17. Invasive micropapillary carcinoma of mixed breast cancer metastasizing to the cervical region and thyroid: report of a rare case.
Yu Y; Wang R; Deng J; Zhou J; Zhou H; Wang J
Gland Surg; 2021 Nov; 10(11):3141-3146. PubMed ID: 34926229
[TBL] [Abstract][Full Text] [Related]
18. A Case Report on Apocrine Encapsulated Papillary Carcinoma of the Breast with Frank Invasion: A Diagnostic Quandary.
Taniguchi K; Yamasaki R; Kajiwara Y; Ichimura K; Yoshino T
Int J Surg Pathol; 2022 Dec; 30(8):939-944. PubMed ID: 35491656
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma with apocrine features of the breast: A case report.
Naito Y; Yamaguchi R; Tanaka M; Saruwatari A; Torii Y; Tsukamoto T; Nishida N; Higaki K
Oncol Lett; 2014 Mar; 7(3):647-650. PubMed ID: 24520287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
